Microbiological Characterization and Clinical Significance of Corynebacterium amycolatum Strains
暂无分享，去创建一个
[1] J. Verhaegen,et al. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. , 1998, Diagnostic microbiology and infectious disease.
[2] G. Yagüe,et al. Acyl phosphatidylglycerol: a major phospholipid of Corynebacterium amycolatum. , 1997, FEMS microbiology letters.
[3] K. Pelz,et al. Fatal sepsis caused by Corynebacterium amycolatum in a premature infant , 1997, Journal of clinical microbiology.
[4] K. Bernard,et al. Clinical microbiology of coryneform bacteria , 1997, Clinical microbiology reviews.
[5] G. Funke,et al. Antimicrobial susceptibility patterns of some recently established coryneform bacteria , 1996, Antimicrobial agents and chemotherapy.
[6] P. Lawson,et al. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum , 1996, Journal of clinical microbiology.
[7] C. Bizet,et al. Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin , 1993, Journal of clinical microbiology.
[8] M. Collins,et al. Corynebacterium amycolatum sp. nov. a new mycolic acid-less Corynebacterium species from human skin , 1988 .